Loading...
•
Mar 31, 2025
Cigna Q1 2025 Earnings Report
The Cigna Group reported strong Q1 2025 results with a significant increase in revenues and a return to profitability.
Key Takeaways
The Cigna Group delivered robust financial results in Q1 2025, with total revenues growing 14% year-over-year to $65.5 billion and net income reaching $1.3 billion. Adjusted income from operations was $1.8 billion, highlighting strong performance across Evernorth Health Services and Cigna Healthcare segments.
Total revenues rose 14% year-over-year to $65.5 billion, driven by strong growth in pharmacy services.
Net income reached $1.3 billion, reversing a net loss of $0.3 billion in Q1 2024.
Adjusted income from operations was $1.8 billion or $6.74 per share.
The company raised its full-year 2025 outlook to at least $29.60 adjusted income per share.
Revenue by Segment
Forward Guidance
Cigna raised its 2025 outlook, expecting at least $29.60 in adjusted income per share, reflecting confidence in strong segment performance and capital deployment.
Positive Outlook
- Raised 2025 adjusted EPS guidance to at least $29.60.
- Expected Evernorth adjusted income from operations to exceed $7.2 billion.
- Expected Cigna Healthcare adjusted income from operations to exceed $4.125 billion.
- Continued share repurchases projected to support EPS growth.
- Anticipated strong performance in pharmacy and specialty services.
Challenges Ahead
- Higher expected medical costs contributing to elevated MCR.
- Impact of HCSC divestiture may reduce customer base in near term.
- Strategic investments may compress near-term operating margins.
- Lower net investment income compared to prior year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...